We narrowed to 29,785 results for: des.2
-
Plasmid#159863PurposeThree-fragment Gateway compatible flourophore for expression in C. elegansDepositorInsert[1-2] ENTR - Fluor - ce-mCardinal(900bp PATCs, NLS, no_atg, no_stop)
ExpressionWormMutationNot applicableAvailable SinceMarch 9, 2021AvailabilityAcademic Institutions and Nonprofits only -
pETDuet1_BCL2L13(1-465aa)-EGFP-TEV-GST (Y213A/I216A/W276A/I279A; deltaLIR1+2)
Plasmid#223782PurposeExpression of recombinant protein for purificationDepositorInsertBCL2L13 soluble part (BCL2L13 Human)
TagsEGFP-TEV-GSTExpressionBacterialMutationY213A/I216A/W276A/I279A; deletion of LIR1+2Available SinceMarch 25, 2025AvailabilityAcademic Institutions and Nonprofits only -
pJT342 Lenti pEF-dCas9-3XFLAG-RYBP + MGA1+2-T2A-tagBFP-P2A-Blast
Plasmid#195541PurposedCas9 effector fusion for manipulating transcriptionDepositorInsertLenti pEF-dCas9-3XFLAG-RYBP + MGA1+2-T2A-tagBFP-P2A-Blast
UseCRISPR and LentiviralTags3XFLAGExpressionMammalianPromoterpEF1aAvailable SinceMay 6, 2024AvailabilityAcademic Institutions and Nonprofits only -
Antibody#219629-rAbPurposeAnti-Neuroligin-3 (mouse) chimeric recombinant antibody with fused human variable and rabbit constant domains; recognizes mouse and human NLGN3. Does not cross-react with other NLGNs.DepositorArticleRecommended ApplicationsFlow Cytometry and ImmunocytochemistryReactivityHuman and MouseSource SpeciesRabbitIsotypeIgGTrial SizeNot available to purchaseAvailable SinceNov. 11, 2025AvailabilityIndustry, Academic Institutions, and Nonprofits
-
pcDNA3.3_SARS2_BA.2.87.1
Plasmid#218679Purposeexpressing SARS-CoV-2 BA.2.87.1 spike protein for pseudovirus productionDepositorInsertSpike (BA.2.87.1)
ExpressionMammalianPromoterCMVAvailable SinceJune 14, 2024AvailabilityAcademic Institutions and Nonprofits only -
pcDNA3.3_SARS2_JN.1
Plasmid#218678Purposeexpressing SARS-CoV-2 JN.1 spike protein for pseudovirus productionDepositorInsertSpike (JN.1)
ExpressionMammalianMutationL455S on the basis of BA.2.86PromoterCMVAvailable SinceJune 26, 2024AvailabilityAcademic Institutions and Nonprofits only -
pcDNA3.3_SARS2_XBB.1.5
Plasmid#196585Purposeexpressing SARS-CoV-2 XBB.1.5 spike protein for pseudovirus productionDepositorInsertSpike (XBB.1.5)
ExpressionMammalianMutationG252V, F486P on the basis of XBBPromoterCMVAvailable SinceMarch 7, 2023AvailabilityAcademic Institutions and Nonprofits only -
SARS-CoV-2 Mpro protease (M165I mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204778PurposeBacterial expression of Sars Cov 2 MPRO M165I mutantDepositorAvailable SinceDec. 1, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (T190I mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204786PurposeBacterial expression of Sars Cov 2 MPRO T190I mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (Q189K mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204784PurposeBacterial expression of Sars Cov 2 MPRO Q189K mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (P132H mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204783PurposeBacterial expression of Sars Cov 2 MPRO P132H mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (N142S mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204782PurposeBacterial expression of Sars Cov 2 MPRO N142S mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (M49T mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204779PurposeBacterial expression of Sars Cov 2 MPRO M49T mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (M491I mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204777PurposeBacterial expression of Sars Cov 2 MPRO M49I mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (G143S mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204776PurposeBacterial expression of Sars Cov 2 MPRO G143S mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (A191V mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204774PurposeBacterial expression of Sars Cov 2 MPRO A191V mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (A193T mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204773PurposeBacterial expression of Sars Cov 2 MPRO A193T mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (A191T mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204772PurposeBacterial expression of Sars Cov 2 MPRO A191T mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (A193S mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204771PurposeBacterial expression of Sars Cov 2 MPRO A193S mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (C145S mutant - catalytically inactive); aliases: 3CLpro, 3C-like
Plasmid#204769PurposeBacterial expression of Sars Cov 2 MPRO C145S mutantDepositorAvailable SinceNov. 30, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits